fungal infections – Page 2

New Strategies to Combat Human Fungal Infections

mycolabadmin

Fungal infections are becoming a major global health threat, causing millions of deaths annually. This research collection presents new and improved ways to treat these infections, including natural compounds like chitosan, beneficial bacteria, new drug combinations, and tests to better understand which treatments work best. The papers showcase innovative approaches beyond traditional antifungal medications to help combat resistant infections.

Eleven new species of Trichoderma (Hypocreaceae, Hypocreales) from China

mycolabadmin

Scientists discovered 11 new species of Trichoderma fungi in China that were isolated from soil and grass plants. These fungi are important because they can produce useful compounds, help control plant diseases, and promote plant growth. The researchers used genetic analysis and microscopy to identify and describe these new species, expanding our knowledge of fungal diversity in China.

Advancing Patient Advocacy in Mycology: Cultivating Collaboration in Education, Research, and Policy

mycolabadmin

This paper highlights how patients with fungal infections and their caregivers are rarely included in discussions about healthcare policies and research funding, unlike patients with cancer or HIV. The authors argue that fungal diseases deserve more attention and resources, and that listening to patient experiences is essential for improving how these diseases are prevented, diagnosed, and treated. They propose that dedicated advocacy organizations, like the MyCARE Foundation, can help bridge this gap and ensure fungal infections receive the policy support and research investment they need.

Cracks in the Curriculum: The Hidden Deficiencies in Fungal Disease Coverage in Medical Books

mycolabadmin

This study examined how well major medical textbooks cover fungal diseases, which kill millions of people annually. Researchers found that books focused on infectious diseases had much better information about fungal infections than general internal medicine textbooks. Most textbooks failed to adequately cover how to prevent fungal infections and diagnose them correctly, which could lead to delayed treatment and worse patient outcomes.

Discovery of novel targets for important human and plant fungal pathogens via an automated computational pipeline HitList

mycolabadmin

Researchers created a computer program called HitList that searches fungal DNA to find new targets for antifungal medications. The program identified 16 promising protein targets that could be attacked by new antifungal drugs, including 8 completely new targets never before considered. This discovery could help develop new antifungal treatments to fight drug-resistant fungal infections in both humans and crops.

Clinical experience of primary subcutaneous mycoses in Shanghai: a retrospective analysis

mycolabadmin

Researchers in Shanghai studied 33 patients with deep skin fungal infections that had become increasingly common in the area. They identified 13 different fungal species causing these infections, most commonly Candida parapsilosis, Trichophyton rubrum, and Sporothrix schenckii. Patients were treated with antifungal medications tailored to the specific fungus and its drug sensitivity, with most patients recovering completely, though some experienced relapses, emphasizing the importance of long-term follow-up care.

Molecular Identification of Candida Species among Iranian Patients: Pursuing Candida auris

mycolabadmin

This study evaluated a simple molecular test called PCR-RFLP to identify different types of Candida fungi in hospitalized patients in Iran. Among 136 patient samples, researchers found eight different Candida species, with common Candida albicans being most prevalent, but other more dangerous species also present. No cases of the emerging pathogen Candida auris were found, though the test method can effectively detect it. The researchers conclude this cost-effective test could be valuable for identifying dangerous fungal infections in developing countries.

Pyrvinium Pamoate Synergizes with Azoles in vitro and in vivo to Exert Antifungal Efficacy Against Candida auris and Other Candida Species

mycolabadmin

Researchers tested a combination of an old antiparasitic drug called pyrvinium pamoate with common antifungal medications called azoles against dangerous drug-resistant fungal infections. While pyrvinium pamoate alone was not very effective, when combined with azoles it significantly improved the treatment of Candida auris infections. Tests in insect larvae showed that the combination improved survival rates better than using azoles alone, suggesting a promising new treatment approach for serious fungal infections.

Optimizing a modified cetyltrimethylammonium bromide protocol for fungal DNA extraction: Insights from multilocus gene amplification

mycolabadmin

This research improves how scientists extract DNA from fungi found in dried fruits and other sources. The modified CTAB method is faster, cheaper, and produces higher quality DNA than commercial kits, without requiring special equipment like liquid nitrogen. The extracted DNA works well for identifying fungal species and detecting fungal diseases in fish, plants, and humans, making it valuable for both research and medical diagnostics.

John Perfect Shares Insights on Infectious Diseases, Antifungal Therapy, and Drug Resistance

mycolabadmin

This interview with Dr. John Perfect, a leading expert in fungal infections, discusses how antifungal treatments have evolved over his 48-year career. He explains that while fungal resistance is a concern, it’s less problematic than bacterial antibiotic resistance because fungi don’t spread resistance through plasmids. Dr. Perfect emphasizes the importance of newer, faster-acting antifungal drugs and combining drug therapy with immune system support to better treat serious fungal infections like cryptococcal meningitis and candidemia.

Research Keyword: fungal infections